Furthermore, the expression of EAAT3 in the NSCLC cell line A549 was dose-dependently repressed by the NF-κB inhibitors BMS 345541 and QNZ-EVP4593 at both the protein and mRNA levels (Fig. 2D–F). This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.